These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 15454174

  • 1. Inhibition of alloresponse by a human trophoblast non-coding RNA suppressing class II transactivator promoter III and major histocompatibility class II expression in murine B-lymphocytes.
    Geirsson A, Bothwell AL, Hammond GL.
    J Heart Lung Transplant; 2004 Sep; 23(9):1077-81. PubMed ID: 15454174
    [Abstract] [Full Text] [Related]

  • 2. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A, Paliwal I, Lynch RJ, Bothwell AL, Hammond GL.
    Transplantation; 2003 Jul 27; 76(2):387-94. PubMed ID: 12883198
    [Abstract] [Full Text] [Related]

  • 3. Human trophoblast noncoding RNA suppresses CIITA promoter III activity in murine B-lymphocytes.
    Geirsson A, Lynch RJ, Paliwal I, Bothwell AL, Hammond GL.
    Biochem Biophys Res Commun; 2003 Feb 14; 301(3):718-24. PubMed ID: 12565840
    [Abstract] [Full Text] [Related]

  • 4. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.
    Sartoris S, Tosi G, De Lerma Barbaro A, Cestari T, Accolla RS.
    Eur J Immunol; 1996 Oct 14; 26(10):2456-60. PubMed ID: 8898960
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
    Shi B, Vinyals A, Alia P, Broceño C, Chen F, Adrover M, Gelpi C, Price JE, Fabra A.
    Int J Biochem Cell Biol; 2006 Oct 14; 38(4):544-62. PubMed ID: 16343978
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y, McDonald J, Perloff E, Butticè G, Schreiber BM, Smith BD.
    Mol Immunol; 2007 Mar 14; 44(7):1709-21. PubMed ID: 16982097
    [Abstract] [Full Text] [Related]

  • 10. Class II transactivator suppresses transcription of thyroid-specific genes.
    Mori-Aoki A, Pietrarelli M, Nakazato M, Caturegli P, Kohn LD, Suzuki K.
    Biochem Biophys Res Commun; 2000 Nov 11; 278(1):58-62. PubMed ID: 11071855
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M, Jager M, Ono SJ.
    Exp Mol Pathol; 2007 Feb 11; 82(1):68-76. PubMed ID: 16650406
    [Abstract] [Full Text] [Related]

  • 12. Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta.
    Harnesk K, Swanberg M, Diez M, Olsson T, Piehl F, Lidman O.
    J Neuroimmunol; 2009 Jul 25; 212(1-2):44-52. PubMed ID: 19481818
    [Abstract] [Full Text] [Related]

  • 13. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb 25; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 14. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
    van der Stoep N, Quinten E, Alblas G, Plancke A, van Eggermond MC, Holling TM, van den Elsen PJ.
    Mol Immunol; 2007 Mar 25; 44(8):2036-46. PubMed ID: 17067677
    [Abstract] [Full Text] [Related]

  • 15. N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.
    Schnappauf F, Hake SB, Camacho Carvajal MM, Bontron S, Lisowska-Grospierre B, Steimle V.
    Eur J Immunol; 2003 Aug 25; 33(8):2337-47. PubMed ID: 12884309
    [Abstract] [Full Text] [Related]

  • 16. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
    Choi YE, Yu HN, Yoon CH, Bae YS.
    Eur J Immunol; 2009 Mar 25; 39(3):858-68. PubMed ID: 19224634
    [Abstract] [Full Text] [Related]

  • 17. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B.
    Br J Dermatol; 2008 May 25; 158(5):930-40. PubMed ID: 18284388
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.